Skip to Main Content

Paper Details

Predicting Toxicity and Response to Pembrolizumab Through Germline Genomic HLA Class 1 Analysis.
JNCI Cancer Spectr
13
2020
-21M, -21T, HLA, HLA Class 1, HLA-1, HLA-1 alleles, HLA-1 genotype, HLA-1 haplotypes, HLA-1 loci, HLA-1-dependent CD8+ T cells, HLA-A and -B haplotype -21M/T, HLA-A and -B leader sequence, HLA-A, -B, and -C, HLA-C, HLAVBSeq, HLAminer, Human, Human leukocyte antigen class 1, Patients, Pembrolizumab, advanced solid tumors, anti-programmed cell death-1, autoimmune diseases, patients, pembrolizumab, peripheral blood mononuclear cells
Author NameAffiliation
Melania PintiliePrincess Margaret Cancer Centre, University Health Network
Philippe L BedardPrincess Margaret Cancer Centre, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughUniversity of Toronto
Lillian L SiuPrincess Margaret Cancer Centre, University Health Network
  • 1 - 5

Datasets

Release 1.2